Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
10.99
-0.41 (-3.60%)
At close: Jun 5, 2026, 4:00 PM EDT
11.33
+0.34 (3.09%)
After-hours: Jun 5, 2026, 7:21 PM EDT
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $125.58 million as of June 5, 2026. Its market cap has increased by 3,156.27% in one year.
Market Cap
125.58M
Enterprise Value
79.32M
1-Year Change
3,156.27%
Ranking
Category
Stock Price
$10.99
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $125.58M, a decrease of -11.21%. That is a compound annual growth rate of -0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 125.58M | 60.79% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 144.82M |
| Molecular Partners AG | 144.58M |
| Spruce Biosciences | 143.68M |
| Agenus | 141.02M |
| TuHURA Biosciences | 139.46M |
| Canton Strategic Holdings | 138.81M |
| Genelux | 136.78M |
| Alpha Cognition | 129.12M |